IGEN/Roche $1 billion dispute may have its day in court
This article was originally published in Clinica
Executive Summary
IGEN International and Roche Diagnostics, which have been battling for more than three years over Roche's alleged breaches of a licensing agreement, will now get a full hearing in October.